Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial

Journal of Dairy Science

Volumn 99, Issue 7, 2016, Pages 5008-5021

  Bogovič Matijašic, Bojana ^a   Obermajer, Tanja ^a   Lipoglavšek, Luka ^a   Sernel, Tjaša ^a   Locatelli, Igor ^a   Kos, Mitja ^a   Šmid, Alenka ^a   Rogelj, Irena ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Irritable bowel syndrome; Metataxonomics; Real time PCR; Synbiotic fermented milk

Indexed keywords

BACTERIAL DNA; RNA 16S; SYNBIOTIC AGENT;

ADMINISTRATION AND DOSAGE; ADOLESCENT; ADULT; AGED; BIFIDOBACTERIUM ANIMALIS; CHEMISTRY; CONTROLLED STUDY; CROATIA; DIETARY FIBER; DOUBLE BLIND PROCEDURE; FECES; FERMENTED MILK PRODUCT; GENETICS; HUMAN; IRRITABLE BOWEL SYNDROME; LACTOBACILLUS ACIDOPHILUS; MICROBIOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SLOVENIA; STREPTOCOCCUS THERMOPHILUS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIFIDOBACTERIUM ANIMALIS; CROATIA; CULTURED MILK PRODUCTS; DIETARY FIBER; DNA, BACTERIAL; DOUBLE-BLIND METHOD; FECES; HUMANS; IRRITABLE BOWEL SYNDROME; LACTOBACILLUS ACIDOPHILUS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SLOVENIA; STREPTOCOCCUS THERMOPHILUS; SYNBIOTICS; YOUNG ADULT;

EID: 84964813081     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2015-10743     Document Type: Article

References (53)

1. Agrawal A., Houghton L.A., Morris J., Reilly B., Guyonnet D., Feuillerat N.G., Schlumberger A., Jakob S., Whorwell P.J. Clinical trial: The effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment. Pharmacol. Ther. 2009, 29:104-114. http://dx.doi.org/10.1111/j.1365-2036.2008.03853.x.
2. Akopyanz N., Bukanov N.O., Westblom T.U., Kresovich S., Berg D.E. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res. 1992, 20:5137-5142. http://dx.doi.org/10.1093/nar/20.19.5137.
3. Alander M., Matto J., Kneifel W., Johansson M., Kogler B., Crittenden R., Mattila-Sandholm T., Saarela M. Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. Int. Dairy J. 2001, 11:817-825. http://dx.doi.org/10.1016/S0958-6946(01)00100-5.
4. Andriulli A., Neri M., Loguercio C., Terreni N., Merla A., Cardarella M.P., Federico A., Chilovi F., Milandri G.L., De Bona M., Cavenati S., Gullini S., Abbiati R., Garbagna N., Cerutti R., Grossi E. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome-A multicenter, randomized study. J. Clin. Gastroenterol. 2008, 42:S218-S223.
5. Bartosch S., Fite A., Macfarlane G.T., McMurdo M.E.T. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol. 2004, 70:3575-3581. http://dx.doi.org/10.1128/AEM.70.6.3575-3581.2004.
6. Benno P., Befrits R., Norin E., Berstad A., Dahlgren A.L., Midtvedt T., Hellström P.M. Is irritable bowel syndrome a dysbiotic bowel syndrome?. Microb. Ecol. Health Dis. 2015, 26:27637. http://dx.doi.org/10.3402/mehd.v26.27637.
7. Bogovič Matijašić B., Obermajer T., Lipoglavšek L., Grabnar I., Avguštin G., Rogelj I. Association of dietary type with fecal microbiota in vegetarians and omnivores in Slovenia. Eur. J. Nutr. 2014, 53:1051-1064. http://dx.doi.org/10.1007/s00394-013-0607-6.
8. Canavan C., West J., Card T. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 2014, 6:71-80. http://dx.doi.org/10.2147/CLEP.S40245.
9. Caporaso J.G., Lauber C.L., Walters W.A., Berg-Lyons D., Huntley J., Fierer N., Owens S.M., Betley J., Fraser L., Bauer M., Gormley N., Gilbert J.A., Smith G., Knight R. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012, 6:1621-1624. http://dx.doi.org/10.1038/ismej.2012.8.
10. Cappello C., Tremolaterra F., Pascariello A., Ciacci C., Iovino P. A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): Effects on symptoms, colonic transit and quality of life. Int. J. Colorectal Dis. 2013, 28:349-358. http://dx.doi.org/10.1007/s00384-012-1552-1.
11. Carroll I.M., Ringel-Kulka T., Siddle J.P., Ringel Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil. 2012, 24:521-530. http://dx.doi.org/10.1111/j.1365-2982.2012.01891.x.
12. Derrien M., Vlieg J.E.T.H. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 2015, 23:354-366. http://dx.doi.org/10.1016/j.tim.2015.03.002.
13. Drossman D.A. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006, 130:1377-1390. http://dx.doi.org/10.1053/j.gastro.2006.03.008.
14. Eloe-Fadrosh E.A., Brady A., Crabtree J., Drabek E.F., Ma B., Mahurkar A., Ravel J., Haverkamp M., Fiorino A.M., Botelho C., Andreyeva I., Hibberd P.L., Fraser C.M. Functional dynamics of the gut microbiome in elderly people during probiotic consumption. Mbio 2015, 6:e00231. http://dx.doi.org/10.1128/mBio.00231-15.
15. Ferraris L., Aires J., Waligora-Dupriet A.J., Butel M.J. New selective medium for selection of bifidobacteria from human feces. Anaerobe 2010, 16:469-471. http://dx.doi.org/10.1016/j.anaerobe.2010.03.008.
16. Fierer N., Jackson J.A., Vilgalys R., Jackson R.B. Assessment of soil microbial community structure by use of taxon-specific quantitative PCR assays. Appl. Environ. Microbiol. 2005, 71:4117-4120. http://dx.doi.org/10.1128/AEM.71.7.4117-4120.2005.
17. Filteau M., Matamoros S., Savard P., Roy D. Molecular monitoring of fecal microbiota in healthy adults following probiotic yogurt intake. PharmaNutrition 2013, 1:123-129. http://dx.doi.org/10.1016/j.phanu.2013.05.002.
18. FAO-WHO (Food and Agricultural Organization of the United Nations and World Health Organization). 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Accessed Mar. 14, 2016. http://www.mesanders.com/probio_report.pdf.
19. Garcia-Albiach R., Jose M., de Felipe P., Angulo S., Morosini M.I., Bravo D., Baquero F., del Campo R. Molecular analysis of yogurt containing Lactobacillus delbrueckii subsp bulgaricus and Streptococcus thermophilus in human intestinal microbiota. Am. J. Clin. Nutr. 2008, 87:91-96.
20. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota-Introducing the concept of prebiotics. J. Nutr. 1995, 125:1401-1412.
21. Gibson G.R., Scott K.P., Rastall R.A., Tuohy K.M., Hotchkiss A., Dubert-Ferrandon A., Gareau M., Murphy E.F., Saulnier D., Loh G., Macfarlane S., Delzenne N., Ringel Y., Kozianowski G., Dickman R., Lenoir-Wijnkoop I., Walker C., Buddington R. Dietary prebiotics: Current status and new definition. Food Sci. Technol. Bull. Funct. Foods 2010, 7:1-19. http://dx.doi.org/10.1616/1476-2137.15880.
22. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., Calder P.C., Sanders M.E. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11:506-514. http://dx.doi.org/10.1038/nrgastro.2014.66.
23. Hong Y.S., Hong K.S., Park M.H., Ahn Y.T., Lee J.H., Huh C.S., Lee J., Kim I.K., Hwang G.S., Kim J.S. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome. J. Clin. Gastroenterol. 2011, 45:415-425. http://dx.doi.org/10.1097/MCG.0b013e318207f76c.
24. Kajander K., Myllyluoma E., Rajilic-Stojanovic M., Kyronpalo S., Rasmussen M., Jarvenpaa S., Zoetendal E.G., De Vos W.M., Vapaatalo H., Korpela R. Clinical trial: Multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment. Pharmacol. Ther. 2008, 27:48-57. http://dx.doi.org/10.1111/j.1365-2036.2007.03542.x.
25. Kim S.W., Suda W., Kim S., Oshima K., Fukuda S., Ohno H., Morita H., Hattori M. Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res. 2013, 20:241-253. http://dx.doi.org/10.1093/dnares/dst006.
26. Konig J., Brummer R.J. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Benef. Microbes 2014, 5:247-261. http://dx.doi.org/10.3920/BM2013.0033.
27. Kozich J.J., Westcott S.L., Baxter N.T., Highlander S.K., Schloss P.D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 2013, 79:5112-5120. http://dx.doi.org/10.1128/AEM.01043-13.
28. Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., Spiller R.C. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491. http://dx.doi.org/10.1053/j.gastro.2005.11.061.
29. Malinen E., Kassinen A., Rinttila T., Palva A. Comparison of real-time PCR with SYBR Green I or 5 '-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 2003, 149:269-277. http://dx.doi.org/10.1099/mic.0.25975-0.
30. Malinen E., Krogius-Kurikka L., Lyra A., Nikkila J., Jaaskelainen A., Rinttila T., Vilpponen-Salmela T., von Wright A.J., Palva A. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J. Gastroenterol. 2010, 16:4532-4540. http://dx.doi.org/10.3748/wjg.v16.i36.4532.
31. Marzotto M., Maffeis C., Paternoster T., Ferrario R., Rizzotti L., Pellegrino M., Dellaglio F., Torriani S. Lactobacillus paracasei A survives gastrointestinal passage and affects the fecal microbiota of healthy infants. Res. Microbiol. 2006, 157:857-866. http://dx.doi.org/10.1016/j.resmic.2006.06.007.
32. Matto J., Fonden R., Tolvanen T., von Wright A., Vilpponen-Salmela T., Satokari R., Saarela M. Intestinal survival and persistence of probiotic Lactobacillus and Bifidobacterium strains administered in triple-strain yoghurt. Int. Dairy J. 2006, 16:1174-1180. http://dx.doi.org/10.1016/j.idairyj.2005.10.007.
33. McNulty N.P., Yatsunenko T., Hsiao A., Faith J.J., Muegge B.D., Goodman A.L., Henrissat B., Oozeer R., Cools-Portier S., Gobert G., Chervaux C., Knights D., Lozupone C.A., Knight R., Duncan A.E., Bain J.R., Muehlbauer M.J., Newgard C.B., Heath A.C., Gordon J.I. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci. Transl. Med. 2011, 3:106ra106. http://dx.doi.org/10.1126/scitranslmed.3002701.
34. Ng S.C., Lam E.F.C., Lam T.T.Y., Chan Y.W., Law W.D., Tse P.C.H., Kamm M.A., Sung J.J.Y., Chan F.K.L., Wu J.C.Y. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome. J. Gastroenterol. Hepatol. 2013, 28:1624-1631. http://dx.doi.org/10.1111/jgh.12306.
35. Palaria A., Johnson-Kanda I., O'Sullivan D.J. Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria. Appl. Environ. Microbiol. 2012, 78:933-940. http://dx.doi.org/10.1128/AEM.05848-11.
36. Quigley E.M.M. Commensal bacteria: The link between IBS and IBD?. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14:497-503. http://dx.doi.org/10.1097/MCO.0b013e328348c033.
37. Rajilić-Stojanović M., Biagi E., Heilig H., Kajander K., Kekkonen R.A., Tims S., De Vos W.M. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011, 141:1792-1801. http://dx.doi.org/10.1053/j.gastro.2011.07.043.
38. Rinttilä T., Kassinen A., Malinen E., Krogius L., Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J. Appl. Microbiol. 2004, 97:1166-1177. http://dx.doi.org/10.1111/j.1365-2672.2004.02409.x.
39. Roberts L.M., McCahon D., Holder R., Wilson S., Hobbs F.D.R. A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome. BMC Gastroenterol. 2013, 13:45. http://dx.doi.org/10.1186/1471-230X-13-45.
40. Savard P., Lamarche B., Paradis M.E., Thiboutot H., Laurin E., Roy D. Impact of Bifidobacterium animalis subsp lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults. Int. J. Food Microbiol. 2011, 149:50-57. http://dx.doi.org/10.1016/j.ijfoodmicro.2010.12.026.
41. Saxelin M., Lassig A., Karjalainen H., Tynkkynen S., Surakka A., Vapaatalo H., Jarvenpaa S., Korpela R., Mutanen M., Hatakka K. Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. Int. J. Food Microbiol. 2010, 144:293-300. http://dx.doi.org/10.1016/j.ijfoodmicro.2010.10.009.
42. Sayuk G.S., Gyawali C.P. Irritable bowel syndrome: Modern concepts and management options. Am. J. Med. 2015, 128:817-827. http://dx.doi.org/10.1016/j.amjmed.2015.01.036.
43. Schloss P.D., Westcott S.L., Ryabin T., Hall J.R., Hartmann M., Hollister E.B., Lesniewski R.A., Oakley B.B., Parks D.H., Robinson C.J., Sahl J.W., Stres B., Thallinger G.G., Van Horn D.J., Weber C.F. Introducing mothur: Open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 2009, 75:7537-7541. http://dx.doi.org/10.1128/AEM.01541-09.
44. Songjinda P., Nakayama J., Tateyama A., Tanaka S., Tsubouchi M., Kiyohara C., Shirakawa T., Sonomoto K. Differences in developing intestinal microbiota between allergic and non-allergic infants: A pilot study in Japan. Biosci. Biotechnol. Biochem. 2007, 71:2338-2342. http://dx.doi.org/10.1271/bbb.70154.
45. Torriani S., Zapparoli G., Dellaglio F. Use of PCR-based methods for rapid differentiation of Lactobacillus delbrueckii subsp bulgaricus and L-delbrueckii subsp lactis. Appl. Environ. Microbiol. 1999, 65:4351-4356.
46. Tsuchiya J., Barreto R., Okura R., Kawakita S., Fesce E., Marotta F. Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome. Chin. J. Dig. Dis. 2004, 5:169-174.
47. Turroni F., Ventura M., Butto L.F., Duranti S., O'Toole P.W., Motherway M.O.C., van Sinderen D. Molecular dialogue between the human gut microbiota and the host: A Lactobacillus and Bifidobacterium perspective. Cell. Mol. Life Sci. 2014, 71:183-203. http://dx.doi.org/10.1007/s00018-013-1318-0.
48. Tušar T., Žerdoner K., Bogovič-Matijašić B., Paveljšek D., Benedik E., Bratanič B., Fidler N., Rogelj I. Cultivable bacteria from milk from Slovenian breastfeeding mothers. Food Technol. Biotechnol. 2014, 52:242-247.
49. Unno T., Choi J.-H., Hur H.-G., Sadowsky M.J., Ahn Y.-T., Huh C.-S., Kim G.-B., Cha C.-J. Changes in human gut microbiota influenced by probiotic fermented milk ingestion. J. Dairy Sci. 2015, 98:3568-3576. http://dx.doi.org/10.3168/jds.2014-8943.
50. van Zanten G.C., Krych L., Roytio H., Forssten S., Lahtinen S.J., Abu Al-Soud W., Sorensen S., Svensson B., Jespersen L., Jakobsen M. Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: A randomized, double-blinded cross-over trial. FEMS Microbiol. Ecol. 2014, 90:225-236. http://dx.doi.org/10.1111/1574-6941.12397.
51. Veiga P., Pons N., Agrawal A., Oozeer R., Guyonnet D., Brazeilles R., Faurie J.-M., Vlieg J.E.T.H., Houghton L.A., Whorwell P.J., Ehrlich S.D., Kennedy S.P. Changes of the human gut microbiome induced by a fermented milk product. Sci. Rep. 2014, 4:6328. http://dx.doi.org/10.1038/srep06328.
52. Wang Q., Garrity G.M., Tiedje J.M., Cole J.R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007, 73:5261-5267. http://dx.doi.org/10.1128/AEM.00062-07.
53. Yoon J.S., Sohn W., Lee O.Y., Lee S.P., Lee K.N., Jun D.W., Lee H.L., Yoon B.C., Choi H.S., Chung W.S., Seo J.G. Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial. J. Gastroenterol. Hepatol. 2014, 29:52-59. http://dx.doi.org/10.1111/jgh.12322.